Pathogenesis of Atherothrombotic Events: From Lumen to Lesion and Beyond.
作者信息
Libby Peter
机构信息
Department of Medicine, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
出版信息
Circulation. 2024 Oct 15;150(16):1217-1219. doi: 10.1161/CIRCULATIONAHA.124.070087. Epub 2024 Oct 14.
Abstract
摘要
相似文献
1
Pathogenesis of Atherothrombotic Events: From Lumen to Lesion and Beyond.动脉粥样硬化血栓形成事件的发病机制：从管腔到病变及其他。
Circulation. 2024 Oct 15;150(16):1217-1219. doi: 10.1161/CIRCULATIONAHA.124.070087. Epub 2024 Oct 14.
2
[Pathology of AtheroThrombosIS (ATIS)].动脉粥样硬化血栓形成（ATIS）的病理学
Drugs. 2010 Nov 1;70 Suppl 1:3-8. doi: 10.2165/00000004-000000000-00000.
3
Interplay between ultrastructural findings and atherothrombotic complications in type 2 diabetes mellitus.2型糖尿病中超微结构发现与动脉粥样硬化血栓形成并发症之间的相互作用。
Cardiovasc Diabetol. 2015 Jul 31;14:96. doi: 10.1186/s12933-015-0261-9.
4
Plaque Rupture and Thrombosis: the Value of the Atherosclerotic Rabbit Model in Defining the Mechanism.斑块破裂与血栓形成：动脉粥样硬化兔模型在阐明机制方面的价值
Curr Atheroscler Rep. 2016 Jun;18(6):29. doi: 10.1007/s11883-016-0587-0.
5
Inflammation in Coronary Atherosclerosis and Its Therapeutic Implications.冠状动脉粥样硬化中的炎症及其治疗意义
Cardiovasc Drugs Ther. 2022 Apr;36(2):347-362. doi: 10.1007/s10557-020-07106-6. Epub 2020 Nov 10.
6
Soluble CD154 is a unique predictor of nonfatal and fatal atherothrombotic events in patients who have end-stage renal disease and are on hemodialysis.可溶性CD154是终末期肾病且正在接受血液透析患者非致死性和致死性动脉粥样硬化血栓形成事件的独特预测指标。
J Am Soc Nephrol. 2007 Apr;18(4):1323-30. doi: 10.1681/ASN.2006070684. Epub 2007 Feb 21.
7
Vulnerable plaque and vulnerable blood: Two critical factors for spontaneous atherothrombosis in mouse models.易损斑块和易损血液：两种导致小鼠模型自发性动脉粥样血栓形成的关键因素。
Atherosclerosis. 2019 May;284:160-164. doi: 10.1016/j.atherosclerosis.2019.03.006. Epub 2019 Mar 11.
8
Pathophysiology of Atherosclerotic Plaque Development.动脉粥样硬化斑块形成的病理生理学
Cardiovasc Hematol Agents Med Chem. 2015;13(1):10-3. doi: 10.2174/1871525713666141218163425.
9
Imaging Reveals the Connection Between Spontaneous Coronary Plaque Ruptures, Atherothrombosis, and Myocardial Infarctions in HypoE/SRBI-/- Mice.影像学揭示低表达/甾醇调节元件结合蛋白1基因敲除小鼠自发性冠状动脉斑块破裂、动脉粥样硬化血栓形成与心肌梗死之间的联系。
J Nucl Med. 2016 Sep;57(9):1420-7. doi: 10.2967/jnumed.115.171132. Epub 2016 Apr 28.
10
Lipoproteins, platelets and atherothrombosis.脂蛋白、血小板与动脉血栓形成。
Rev Esp Cardiol. 2009 Oct;62(10):1161-78. doi: 10.1016/s1885-5857(09)73331-6.
引用本文的文献
1
Acute coronary syndromes: mechanisms, challenges, and new opportunities.急性冠状动脉综合征：机制、挑战与新机遇
Eur Heart J. 2025 Aug 1;46(29):2866-2889. doi: 10.1093/eurheartj/ehaf289.
2
Levo-corydalmine derived from Rhizoma Corydalis suppresses Ox-LDL-induced endothelial cell activation and improves vasodilatation by regulating the DDIT3-eNOS pathway.延胡索左旋紫堇碱通过调节DDIT3-eNOS通路抑制氧化型低密度脂蛋白诱导的内皮细胞活化并改善血管舒张功能。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr 7. doi: 10.1007/s00210-025-04110-1.
3
Combining Colchicine and Antiplatelet Therapy to Tackle Atherothrombosis: A Paradigm in Transition?联合秋水仙碱与抗血小板治疗应对动脉粥样硬化血栓形成：是一种正在转变的模式吗？
Int J Mol Sci. 2025 Jan 28;26(3):1136. doi: 10.3390/ijms26031136.
本文引用的文献
1
Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial.依洛尤单抗对他汀类药物治疗患者冠状动脉疾病进展的影响：GLAGOV 随机临床试验。
JAMA. 2016 Dec 13;316(22):2373-2384. doi: 10.1001/jama.2016.16951.
2
Mechanisms of acute coronary syndromes and their implications for therapy.急性冠状动脉综合征的机制及其对治疗的意义。
N Engl J Med. 2013 May 23;368(21):2004-13. doi: 10.1056/NEJMra1216063.
3
Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995.稳定与不稳定：冠状动脉粥样硬化的两面。1995年保罗·达德利·怀特讲座
Circulation. 1996 Oct 15;94(8):2013-20. doi: 10.1161/01.cir.94.8.2013.
4
Molecular bases of the acute coronary syndromes.急性冠状动脉综合征的分子基础
Circulation. 1995 Jun 1;91(11):2844-50. doi: 10.1161/01.cir.91.11.2844.
5
Reduction of infarct size following coronary occlusion.冠状动脉闭塞后梗死面积的缩小。
Circ Res. 1974 Sep;35 Suppl 3:192-201.
Zotero 插件